Medpace Hldgs Q2 EPS $1.93 Beats $1.91 Estimate, Sales $460.90M Beat $433.69M Estimate
Portfolio Pulse from Benzinga Newsdesk
Medpace Hldgs (NASDAQ:MEDP) reported Q2 earnings of $1.93 per share, beating the analyst consensus estimate of $1.91 by 1.05%. This is a 32.19% increase from the same period last year. The company also reported quarterly sales of $460.90 million, beating the analyst consensus estimate of $433.69 million by 6.27%, a 31.23% increase from the same period last year.
July 24, 2023 | 8:18 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Medpace Hldgs reported better than expected Q2 earnings and sales, which could positively impact its stock price in the short term.
Medpace Hldgs reported Q2 earnings and sales that beat analyst estimates. This is generally seen as a positive signal by the market and could lead to an increase in the company's stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100